MedTrace Logo

Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT

NCT06360627 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-04-11

No results posted yet for this study

Summary

Evaluation of ultra low dose protocols and Iomeron 400 contrast in PCD-CT

Conditions

Interventions

RADIATION

Computed Tomography

Computed Tomography CHEST

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-20
Primary Completion
2027-03-31
Completion
2027-12-01

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06360627 on ClinicalTrials.gov